<?xml version="1.0" encoding="UTF-8"?>
<p id="Par148">An alternative, simplified regime for HSE involves administering acyclovir intravenously at 10â€“15 mg/kg per dose 8 hourly for 21 days [
 <xref ref-type="bibr" rid="CR6">6</xref>]. It has also been suggested that all patients should have a CSF HSV PCR negative to confirm that treatment can be stopped [
 <xref ref-type="bibr" rid="CR47">47</xref>]. Some patients have benefitted from a second course of acyclovir, which supports the hypothesis that the virus has not been completely inactivated and it may be related if a shorter course of acyclovir has been given [
 <xref ref-type="bibr" rid="CR48">48</xref>]. Suppressive acyclovir treatment for a period of 6 months has been associated with less damage and fewer episodes of recurrence [
 <xref ref-type="bibr" rid="CR6">6</xref>]. It is most likely that patients with post-infectious encephalopathy will benefit from steroid therapy rather than acyclovir [
 <xref ref-type="bibr" rid="CR49">49</xref>].
</p>
